A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey

Clinical trial NCT02954692 · COMPLETED

Trial details

NCT number

NCT02954692

Sponsor

Sanofi

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2016-11-30

Primary completion

2017-12-22

Enrollment

112

View on ClinicalTrials.gov